Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:( pharmacokinetics pharmacodynamics). Showing records 1 – 30 of 185 total matches.

[1] [2] [3] [4] [5] [6] [7]

Search Limiters

Last 2 Years | English Only

Universities

Degrees

Languages

Country

▼ Search Limiters


University of Manchester

1. Felton, Timothy. Antimicrobial therapy in critically ill patients: Improving clinical outcomes using a translational pharmacological approach.

Degree: 2014, University of Manchester

Pulmonary infections in critically ill patients are common, frequently lethal and treatment may be complicated by bacterial resistance. Piperacillin-tazobactam (PTZ) is a broad-spectrum β-lactam antibiotic,… (more)

Subjects/Keywords: Pharmacokinetics; Pharmacodynamics; Piperacillin-tazobactam

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Felton, T. (2014). Antimicrobial therapy in critically ill patients: Improving clinical outcomes using a translational pharmacological approach. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:235681

Chicago Manual of Style (16th Edition):

Felton, Timothy. “Antimicrobial therapy in critically ill patients: Improving clinical outcomes using a translational pharmacological approach.” 2014. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:235681.

MLA Handbook (7th Edition):

Felton, Timothy. “Antimicrobial therapy in critically ill patients: Improving clinical outcomes using a translational pharmacological approach.” 2014. Web. 07 Aug 2020.

Vancouver:

Felton T. Antimicrobial therapy in critically ill patients: Improving clinical outcomes using a translational pharmacological approach. [Internet] [Doctoral dissertation]. University of Manchester; 2014. [cited 2020 Aug 07]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:235681.

Council of Science Editors:

Felton T. Antimicrobial therapy in critically ill patients: Improving clinical outcomes using a translational pharmacological approach. [Doctoral Dissertation]. University of Manchester; 2014. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:235681


Harvard University

2. Tanudra, Maria. Leveraging the Dynamic in Vitro Hollow Fiber Infection Model in Determining Optimal Clinical Dose of β-Lactam and β-Lactamase Inhibitor Combinations.

Degree: ALM, 2018, Harvard University

Infectious disease is one of the top ten leading causes of death worldwide (WHO, 2017). Emergence of new mechanisms of antibiotic resistance continually rises and… (more)

Subjects/Keywords: Hollow Fiber System; Pharmacokinetics/Pharmacodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tanudra, M. (2018). Leveraging the Dynamic in Vitro Hollow Fiber Infection Model in Determining Optimal Clinical Dose of β-Lactam and β-Lactamase Inhibitor Combinations. (Masters Thesis). Harvard University. Retrieved from http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004045

Chicago Manual of Style (16th Edition):

Tanudra, Maria. “Leveraging the Dynamic in Vitro Hollow Fiber Infection Model in Determining Optimal Clinical Dose of β-Lactam and β-Lactamase Inhibitor Combinations.” 2018. Masters Thesis, Harvard University. Accessed August 07, 2020. http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004045.

MLA Handbook (7th Edition):

Tanudra, Maria. “Leveraging the Dynamic in Vitro Hollow Fiber Infection Model in Determining Optimal Clinical Dose of β-Lactam and β-Lactamase Inhibitor Combinations.” 2018. Web. 07 Aug 2020.

Vancouver:

Tanudra M. Leveraging the Dynamic in Vitro Hollow Fiber Infection Model in Determining Optimal Clinical Dose of β-Lactam and β-Lactamase Inhibitor Combinations. [Internet] [Masters thesis]. Harvard University; 2018. [cited 2020 Aug 07]. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004045.

Council of Science Editors:

Tanudra M. Leveraging the Dynamic in Vitro Hollow Fiber Infection Model in Determining Optimal Clinical Dose of β-Lactam and β-Lactamase Inhibitor Combinations. [Masters Thesis]. Harvard University; 2018. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004045


University of Manchester

3. Felton, Timothy. Antimicrobial therapy in critically ill patients : improving clinical outcomes using a translational pharmacological approach.

Degree: PhD, 2014, University of Manchester

 Pulmonary infections in critically ill patients are common, frequently lethal and treatment may be complicated by bacterial resistance. Piperacillin-tazobactam (PTZ) is a broad-spectrum β-lactam antibiotic,… (more)

Subjects/Keywords: 615.1; Pharmacokinetics; Pharmacodynamics; Piperacillin-tazobactam

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Felton, T. (2014). Antimicrobial therapy in critically ill patients : improving clinical outcomes using a translational pharmacological approach. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/antimicrobial-therapy-in-critically-ill-patients-improving-clinical-outcomes-using-a-translational-pharmacological-approach(afffd886-c447-4974-ab0b-a9e8a8c8f2b2).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626967

Chicago Manual of Style (16th Edition):

Felton, Timothy. “Antimicrobial therapy in critically ill patients : improving clinical outcomes using a translational pharmacological approach.” 2014. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. https://www.research.manchester.ac.uk/portal/en/theses/antimicrobial-therapy-in-critically-ill-patients-improving-clinical-outcomes-using-a-translational-pharmacological-approach(afffd886-c447-4974-ab0b-a9e8a8c8f2b2).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626967.

MLA Handbook (7th Edition):

Felton, Timothy. “Antimicrobial therapy in critically ill patients : improving clinical outcomes using a translational pharmacological approach.” 2014. Web. 07 Aug 2020.

Vancouver:

Felton T. Antimicrobial therapy in critically ill patients : improving clinical outcomes using a translational pharmacological approach. [Internet] [Doctoral dissertation]. University of Manchester; 2014. [cited 2020 Aug 07]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/antimicrobial-therapy-in-critically-ill-patients-improving-clinical-outcomes-using-a-translational-pharmacological-approach(afffd886-c447-4974-ab0b-a9e8a8c8f2b2).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626967.

Council of Science Editors:

Felton T. Antimicrobial therapy in critically ill patients : improving clinical outcomes using a translational pharmacological approach. [Doctoral Dissertation]. University of Manchester; 2014. Available from: https://www.research.manchester.ac.uk/portal/en/theses/antimicrobial-therapy-in-critically-ill-patients-improving-clinical-outcomes-using-a-translational-pharmacological-approach(afffd886-c447-4974-ab0b-a9e8a8c8f2b2).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626967


University of Melbourne

4. Gwee, Amanda. Vancomycin pharmacokinetics and pharmacodynamics in young infants.

Degree: 2018, University of Melbourne

 Vancomycin is a glycopeptide antibiotic commonly used for the treatment of late-onset sepsis in young infants. Vancomycin dosing is challenging in young infants due to… (more)

Subjects/Keywords: vancomycin; glycopeptide; pharmacokinetics; pharmacodynamics; Staphylococcus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gwee, A. (2018). Vancomycin pharmacokinetics and pharmacodynamics in young infants. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/221681

Chicago Manual of Style (16th Edition):

Gwee, Amanda. “Vancomycin pharmacokinetics and pharmacodynamics in young infants.” 2018. Doctoral Dissertation, University of Melbourne. Accessed August 07, 2020. http://hdl.handle.net/11343/221681.

MLA Handbook (7th Edition):

Gwee, Amanda. “Vancomycin pharmacokinetics and pharmacodynamics in young infants.” 2018. Web. 07 Aug 2020.

Vancouver:

Gwee A. Vancomycin pharmacokinetics and pharmacodynamics in young infants. [Internet] [Doctoral dissertation]. University of Melbourne; 2018. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/11343/221681.

Council of Science Editors:

Gwee A. Vancomycin pharmacokinetics and pharmacodynamics in young infants. [Doctoral Dissertation]. University of Melbourne; 2018. Available from: http://hdl.handle.net/11343/221681


University of Manitoba

5. Calic, Divna. A pharmacokinetic/pharmacodynamic evaluation of cefazolin antimicrobial prophylaxis in cardiac surgery with cardiopulmonary bypass.

Degree: Pharmacy, 2020, University of Manitoba

 Surgical site infections (SSI) following cardiac surgery result in significant patient morbidity and mortality. Antimicrobial prophylaxis (AP) with cefazolin is a core strategy for preventing… (more)

Subjects/Keywords: Pharmacokinetics; Pharmacodynamics; Cefazolin; Cardiac surgery

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Calic, D. (2020). A pharmacokinetic/pharmacodynamic evaluation of cefazolin antimicrobial prophylaxis in cardiac surgery with cardiopulmonary bypass. (Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/34632

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Calic, Divna. “A pharmacokinetic/pharmacodynamic evaluation of cefazolin antimicrobial prophylaxis in cardiac surgery with cardiopulmonary bypass.” 2020. Thesis, University of Manitoba. Accessed August 07, 2020. http://hdl.handle.net/1993/34632.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Calic, Divna. “A pharmacokinetic/pharmacodynamic evaluation of cefazolin antimicrobial prophylaxis in cardiac surgery with cardiopulmonary bypass.” 2020. Web. 07 Aug 2020.

Vancouver:

Calic D. A pharmacokinetic/pharmacodynamic evaluation of cefazolin antimicrobial prophylaxis in cardiac surgery with cardiopulmonary bypass. [Internet] [Thesis]. University of Manitoba; 2020. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/1993/34632.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Calic D. A pharmacokinetic/pharmacodynamic evaluation of cefazolin antimicrobial prophylaxis in cardiac surgery with cardiopulmonary bypass. [Thesis]. University of Manitoba; 2020. Available from: http://hdl.handle.net/1993/34632

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Temple University

6. Wang, Shining. DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS.

Degree: PhD, 2008, Temple University

Pharmaceutics

EGFR inhibitors, such as gefitinib, are examples of targeted anticancer drugs whose drug sensitivity is related to gene mutations that adds a pharmacogenetic [PG]… (more)

Subjects/Keywords: Health Sciences, Pharmacy; pharmacokinetics; pharmacodynamics; gefitinib; glioblastoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wang, S. (2008). DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,2535

Chicago Manual of Style (16th Edition):

Wang, Shining. “DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS.” 2008. Doctoral Dissertation, Temple University. Accessed August 07, 2020. http://digital.library.temple.edu/u?/p245801coll10,2535.

MLA Handbook (7th Edition):

Wang, Shining. “DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS.” 2008. Web. 07 Aug 2020.

Vancouver:

Wang S. DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS. [Internet] [Doctoral dissertation]. Temple University; 2008. [cited 2020 Aug 07]. Available from: http://digital.library.temple.edu/u?/p245801coll10,2535.

Council of Science Editors:

Wang S. DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS. [Doctoral Dissertation]. Temple University; 2008. Available from: http://digital.library.temple.edu/u?/p245801coll10,2535


University of Otago

7. Wright, Daniel Frank. Model-based Drug Dosing .

Degree: 2013, University of Otago

 The safe and effective use of medicines requires that prescribers use the right drug for the right patient at the right dose. The choice of… (more)

Subjects/Keywords: warfarin; simvastatin; allopurinol; pharmacokinetics; pharmacodynamics; modelling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wright, D. F. (2013). Model-based Drug Dosing . (Doctoral Dissertation). University of Otago. Retrieved from http://hdl.handle.net/10523/4398

Chicago Manual of Style (16th Edition):

Wright, Daniel Frank. “Model-based Drug Dosing .” 2013. Doctoral Dissertation, University of Otago. Accessed August 07, 2020. http://hdl.handle.net/10523/4398.

MLA Handbook (7th Edition):

Wright, Daniel Frank. “Model-based Drug Dosing .” 2013. Web. 07 Aug 2020.

Vancouver:

Wright DF. Model-based Drug Dosing . [Internet] [Doctoral dissertation]. University of Otago; 2013. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10523/4398.

Council of Science Editors:

Wright DF. Model-based Drug Dosing . [Doctoral Dissertation]. University of Otago; 2013. Available from: http://hdl.handle.net/10523/4398


University of Sydney

8. Kim, Hannah Yejin. Personalised Medicine in the Treatment of Cancer .

Degree: 2018, University of Sydney

 Understanding of pharmacokinetic-pharmacodynamic relationship for a given drug, and factors determining this, is an important part of personalised medicine in terms of choosing the correct… (more)

Subjects/Keywords: actinomycin D; dabrafenib; trametinib; pharmacokinetics; pharmacogenetics; pharmacodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kim, H. Y. (2018). Personalised Medicine in the Treatment of Cancer . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/20103

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kim, Hannah Yejin. “Personalised Medicine in the Treatment of Cancer .” 2018. Thesis, University of Sydney. Accessed August 07, 2020. http://hdl.handle.net/2123/20103.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kim, Hannah Yejin. “Personalised Medicine in the Treatment of Cancer .” 2018. Web. 07 Aug 2020.

Vancouver:

Kim HY. Personalised Medicine in the Treatment of Cancer . [Internet] [Thesis]. University of Sydney; 2018. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2123/20103.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kim HY. Personalised Medicine in the Treatment of Cancer . [Thesis]. University of Sydney; 2018. Available from: http://hdl.handle.net/2123/20103

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Southern California

9. Chen, Xiaoying. Linkers in transferrin fusion proteins: effects on pharmacokinetics and pharmacodynamics.

Degree: PhD, Pharmaceutical Sciences, 2011, University of Southern California

 Recombinant fusion proteins have become an important class of biomolecules since the invention of recombinant DNA technology. As an indispensable component of recombinant fusion proteins,… (more)

Subjects/Keywords: linker; fusion protein; transferrin; pharmacokinetics; pharmacodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chen, X. (2011). Linkers in transferrin fusion proteins: effects on pharmacokinetics and pharmacodynamics. (Doctoral Dissertation). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/637770/rec/3837

Chicago Manual of Style (16th Edition):

Chen, Xiaoying. “Linkers in transferrin fusion proteins: effects on pharmacokinetics and pharmacodynamics.” 2011. Doctoral Dissertation, University of Southern California. Accessed August 07, 2020. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/637770/rec/3837.

MLA Handbook (7th Edition):

Chen, Xiaoying. “Linkers in transferrin fusion proteins: effects on pharmacokinetics and pharmacodynamics.” 2011. Web. 07 Aug 2020.

Vancouver:

Chen X. Linkers in transferrin fusion proteins: effects on pharmacokinetics and pharmacodynamics. [Internet] [Doctoral dissertation]. University of Southern California; 2011. [cited 2020 Aug 07]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/637770/rec/3837.

Council of Science Editors:

Chen X. Linkers in transferrin fusion proteins: effects on pharmacokinetics and pharmacodynamics. [Doctoral Dissertation]. University of Southern California; 2011. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/637770/rec/3837


Universiteit Utrecht

10. Keizer, R.J. Pharmacometrics in early clinical drug development.

Degree: 2010, Universiteit Utrecht

 Pharmacometrics, the science of quantitative clinical pharmacology, has been recognized as one of the main research fields able to improve efficiency in drug development, and… (more)

Subjects/Keywords: Farmacie; pharmacometrics; pharmacokinetics; pharmacodynamics; pharmacodynamics; drug development; oncology; cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Keizer, R. J. (2010). Pharmacometrics in early clinical drug development. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/179786

Chicago Manual of Style (16th Edition):

Keizer, R J. “Pharmacometrics in early clinical drug development.” 2010. Doctoral Dissertation, Universiteit Utrecht. Accessed August 07, 2020. http://dspace.library.uu.nl:8080/handle/1874/179786.

MLA Handbook (7th Edition):

Keizer, R J. “Pharmacometrics in early clinical drug development.” 2010. Web. 07 Aug 2020.

Vancouver:

Keizer RJ. Pharmacometrics in early clinical drug development. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2010. [cited 2020 Aug 07]. Available from: http://dspace.library.uu.nl:8080/handle/1874/179786.

Council of Science Editors:

Keizer RJ. Pharmacometrics in early clinical drug development. [Doctoral Dissertation]. Universiteit Utrecht; 2010. Available from: http://dspace.library.uu.nl:8080/handle/1874/179786

11. 大島, 一浩. Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa : メロペネム耐性緑膿菌による肺炎に対する高用量メロペネム(6g/day)の効果の検討.

Degree: 博士(医学), 2016, Nagasaki University / 長崎大学

 High-dose meropenem (MEPM; 6 g/day) has been approved as a treatment for purulent meningitis; however, little is known regarding its in vivo efficacy in refractory… (more)

Subjects/Keywords: high dose; meropenem; pharmacokinetics/pharmacodynamics; meropenem-resistant Pseudomonas aeruginosa

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

大島, . (2016). Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa : メロペネム耐性緑膿菌による肺炎に対する高用量メロペネム(6g/day)の効果の検討. (Thesis). Nagasaki University / 長崎大学. Retrieved from http://hdl.handle.net/10069/37694

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

大島, 一浩. “Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa : メロペネム耐性緑膿菌による肺炎に対する高用量メロペネム(6g/day)の効果の検討.” 2016. Thesis, Nagasaki University / 長崎大学. Accessed August 07, 2020. http://hdl.handle.net/10069/37694.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

大島, 一浩. “Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa : メロペネム耐性緑膿菌による肺炎に対する高用量メロペネム(6g/day)の効果の検討.” 2016. Web. 07 Aug 2020.

Vancouver:

大島 . Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa : メロペネム耐性緑膿菌による肺炎に対する高用量メロペネム(6g/day)の効果の検討. [Internet] [Thesis]. Nagasaki University / 長崎大学; 2016. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10069/37694.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

大島 . Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa : メロペネム耐性緑膿菌による肺炎に対する高用量メロペネム(6g/day)の効果の検討. [Thesis]. Nagasaki University / 長崎大学; 2016. Available from: http://hdl.handle.net/10069/37694

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

12. Oliveira, Juliana da Silva [UNESP]. Avaliação de Tecnologia em Saúde: fatores associados ao nível sérico de vancomicina e impacto do ajuste de dose sobre o prognóstico de pacientes adultos internados no Hospital das Clínicas da Faculdade de Medicina de Botucatu.

Degree: 2016, Universidade Estadual Paulista

Objetivos: Questionamentos têm sido lançados sobre a eficácia das formulações genéricas de vancomicina, empregadas com frequência nos países em desenvolvimento. No entanto, a grande disponibilidade… (more)

Subjects/Keywords: Vancomicina; Farmacocinética; Farmacodinâmica; Prognóstico; Vancomycin; Pharmacokinetics; Pharmacodynamics; Outcome

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Oliveira, J. d. S. [. (2016). Avaliação de Tecnologia em Saúde: fatores associados ao nível sérico de vancomicina e impacto do ajuste de dose sobre o prognóstico de pacientes adultos internados no Hospital das Clínicas da Faculdade de Medicina de Botucatu. (Thesis). Universidade Estadual Paulista. Retrieved from http://hdl.handle.net/11449/143843

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Oliveira, Juliana da Silva [UNESP]. “Avaliação de Tecnologia em Saúde: fatores associados ao nível sérico de vancomicina e impacto do ajuste de dose sobre o prognóstico de pacientes adultos internados no Hospital das Clínicas da Faculdade de Medicina de Botucatu.” 2016. Thesis, Universidade Estadual Paulista. Accessed August 07, 2020. http://hdl.handle.net/11449/143843.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Oliveira, Juliana da Silva [UNESP]. “Avaliação de Tecnologia em Saúde: fatores associados ao nível sérico de vancomicina e impacto do ajuste de dose sobre o prognóstico de pacientes adultos internados no Hospital das Clínicas da Faculdade de Medicina de Botucatu.” 2016. Web. 07 Aug 2020.

Vancouver:

Oliveira JdS[. Avaliação de Tecnologia em Saúde: fatores associados ao nível sérico de vancomicina e impacto do ajuste de dose sobre o prognóstico de pacientes adultos internados no Hospital das Clínicas da Faculdade de Medicina de Botucatu. [Internet] [Thesis]. Universidade Estadual Paulista; 2016. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/11449/143843.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Oliveira JdS[. Avaliação de Tecnologia em Saúde: fatores associados ao nível sérico de vancomicina e impacto do ajuste de dose sobre o prognóstico de pacientes adultos internados no Hospital das Clínicas da Faculdade de Medicina de Botucatu. [Thesis]. Universidade Estadual Paulista; 2016. Available from: http://hdl.handle.net/11449/143843

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

13. Δελής, Γεώργιος. Φαρμακοκινητική / φαρμακοδυναμική συσχέτιση της αμοξικιλλίνης στο πρόβατο.

Degree: 2009, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

Amoxicillin (AMX), a semi-synthetic, broad-spectrum α-amino-p-hydroxybenzylpenicillin has been long used in veterinary medical practice for the treatment of bacterial respiratory, urinary, gastrointestinal, dermal, dental and… (more)

Subjects/Keywords: Αμοξικιλλίνη; Φαρμακοκινητική; Φαρμακοδυναμική; Συσχέτιση; Πρόβατα; Amoxicillin; Pharmacokinetics; Pharmacodynamics; Correlation; Sheeps

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Δελής, . . (2009). Φαρμακοκινητική / φαρμακοδυναμική συσχέτιση της αμοξικιλλίνης στο πρόβατο. (Thesis). Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Retrieved from http://hdl.handle.net/10442/hedi/19233

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Δελής, Γεώργιος. “Φαρμακοκινητική / φαρμακοδυναμική συσχέτιση της αμοξικιλλίνης στο πρόβατο.” 2009. Thesis, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Accessed August 07, 2020. http://hdl.handle.net/10442/hedi/19233.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Δελής, Γεώργιος. “Φαρμακοκινητική / φαρμακοδυναμική συσχέτιση της αμοξικιλλίνης στο πρόβατο.” 2009. Web. 07 Aug 2020.

Vancouver:

Δελής . Φαρμακοκινητική / φαρμακοδυναμική συσχέτιση της αμοξικιλλίνης στο πρόβατο. [Internet] [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2009. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10442/hedi/19233.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Δελής . Φαρμακοκινητική / φαρμακοδυναμική συσχέτιση της αμοξικιλλίνης στο πρόβατο. [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2009. Available from: http://hdl.handle.net/10442/hedi/19233

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Cincinnati

14. Dave, Nimita D. Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole.

Degree: PhD, Pharmacy: Pharmaceutical Sciences/Biopharmaceutics, 2013, University of Cincinnati

 The lack of well-identified targets and limited access of drugs across the blood-brain and blood- tumor barriers are major impediments to the treatment of brain… (more)

Subjects/Keywords: Pharmaceuticals; pharmacokinetics; pharmacodynamics; letrozole; brain tumor; preclinical; glioma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dave, N. D. (2013). Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole. (Doctoral Dissertation). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1368013158

Chicago Manual of Style (16th Edition):

Dave, Nimita D. “Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole.” 2013. Doctoral Dissertation, University of Cincinnati. Accessed August 07, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1368013158.

MLA Handbook (7th Edition):

Dave, Nimita D. “Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole.” 2013. Web. 07 Aug 2020.

Vancouver:

Dave ND. Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole. [Internet] [Doctoral dissertation]. University of Cincinnati; 2013. [cited 2020 Aug 07]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1368013158.

Council of Science Editors:

Dave ND. Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole. [Doctoral Dissertation]. University of Cincinnati; 2013. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1368013158


The Ohio State University

15. Aimiuwu, Josephine Eki. Modulation of Pharmacologic Effects of 5-Azacytidine by Ribonucleotide Reductase Antisense GTI-2040.

Degree: PhD, Pharmacy, 2011, The Ohio State University

 Cancer, like most human diseases is complex and the therapeutic approaches available to treat this disease have limited efficacy. Therefore, combination studies of two or… (more)

Subjects/Keywords: Pharmaceuticals; preclinical; clinical pharmacokinetics/pharmacodynamics; and drug development

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Aimiuwu, J. E. (2011). Modulation of Pharmacologic Effects of 5-Azacytidine by Ribonucleotide Reductase Antisense GTI-2040. (Doctoral Dissertation). The Ohio State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=osu1292851882

Chicago Manual of Style (16th Edition):

Aimiuwu, Josephine Eki. “Modulation of Pharmacologic Effects of 5-Azacytidine by Ribonucleotide Reductase Antisense GTI-2040.” 2011. Doctoral Dissertation, The Ohio State University. Accessed August 07, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=osu1292851882.

MLA Handbook (7th Edition):

Aimiuwu, Josephine Eki. “Modulation of Pharmacologic Effects of 5-Azacytidine by Ribonucleotide Reductase Antisense GTI-2040.” 2011. Web. 07 Aug 2020.

Vancouver:

Aimiuwu JE. Modulation of Pharmacologic Effects of 5-Azacytidine by Ribonucleotide Reductase Antisense GTI-2040. [Internet] [Doctoral dissertation]. The Ohio State University; 2011. [cited 2020 Aug 07]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1292851882.

Council of Science Editors:

Aimiuwu JE. Modulation of Pharmacologic Effects of 5-Azacytidine by Ribonucleotide Reductase Antisense GTI-2040. [Doctoral Dissertation]. The Ohio State University; 2011. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1292851882


University of Cincinnati

16. Samineni, Divya. Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin.

Degree: PhD, Pharmacy: Pharmaceutical Sciences/Biopharmaceutics, 2011, University of Cincinnati

  Treatment of dyslipidemia in HIV-infected persons is commonly required with the use of protease inhibitors (PIs) which may be restricted by drug-drug interactions between… (more)

Subjects/Keywords: Pharmaceuticals; Pharmacokinetics; Pharmacodynamics; Pharmacogenomics; Rosuvastatin; Darunavir; OATP1B1 Uptake

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Samineni, D. (2011). Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin. (Doctoral Dissertation). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1314040722

Chicago Manual of Style (16th Edition):

Samineni, Divya. “Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin.” 2011. Doctoral Dissertation, University of Cincinnati. Accessed August 07, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1314040722.

MLA Handbook (7th Edition):

Samineni, Divya. “Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin.” 2011. Web. 07 Aug 2020.

Vancouver:

Samineni D. Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin. [Internet] [Doctoral dissertation]. University of Cincinnati; 2011. [cited 2020 Aug 07]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1314040722.

Council of Science Editors:

Samineni D. Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin. [Doctoral Dissertation]. University of Cincinnati; 2011. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1314040722


Universiteit Utrecht

17. Zandvliet, A.S. Population pharmacokinetic and pharmacodynamic modeling and simulation of the investigational anticancer agent indisulam.

Degree: 2007, Universiteit Utrecht

 Indisulam is an investigational anticancer agent that is currently being evaluated in phase II clinical studies. The aim of this thesis was to develop a… (more)

Subjects/Keywords: Farmacie; pharmacokinetics; pharmacodynamics; indisulam; modeling; simulation; clinical; oncology; pharmacology; myelosuppression; neutropenia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zandvliet, A. S. (2007). Population pharmacokinetic and pharmacodynamic modeling and simulation of the investigational anticancer agent indisulam. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/22763

Chicago Manual of Style (16th Edition):

Zandvliet, A S. “Population pharmacokinetic and pharmacodynamic modeling and simulation of the investigational anticancer agent indisulam.” 2007. Doctoral Dissertation, Universiteit Utrecht. Accessed August 07, 2020. http://dspace.library.uu.nl:8080/handle/1874/22763.

MLA Handbook (7th Edition):

Zandvliet, A S. “Population pharmacokinetic and pharmacodynamic modeling and simulation of the investigational anticancer agent indisulam.” 2007. Web. 07 Aug 2020.

Vancouver:

Zandvliet AS. Population pharmacokinetic and pharmacodynamic modeling and simulation of the investigational anticancer agent indisulam. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2007. [cited 2020 Aug 07]. Available from: http://dspace.library.uu.nl:8080/handle/1874/22763.

Council of Science Editors:

Zandvliet AS. Population pharmacokinetic and pharmacodynamic modeling and simulation of the investigational anticancer agent indisulam. [Doctoral Dissertation]. Universiteit Utrecht; 2007. Available from: http://dspace.library.uu.nl:8080/handle/1874/22763


Universiteit Utrecht

18. Leijen, S. Development of Combination Therapy with Anti-Cancer Drugs.

Degree: 2013, Universiteit Utrecht

 This thesis describes early clinical trials with anti-cancer drugs in combination with commonly applied and registered chemotherapy and single agent studies with compounds that are… (more)

Subjects/Keywords: Farmacie; Drug development; Cancer; Clinical trial; Pharmacokinetics; Pharmacodynamics; Chemotherapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Leijen, S. (2013). Development of Combination Therapy with Anti-Cancer Drugs. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/267996

Chicago Manual of Style (16th Edition):

Leijen, S. “Development of Combination Therapy with Anti-Cancer Drugs.” 2013. Doctoral Dissertation, Universiteit Utrecht. Accessed August 07, 2020. http://dspace.library.uu.nl:8080/handle/1874/267996.

MLA Handbook (7th Edition):

Leijen, S. “Development of Combination Therapy with Anti-Cancer Drugs.” 2013. Web. 07 Aug 2020.

Vancouver:

Leijen S. Development of Combination Therapy with Anti-Cancer Drugs. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2013. [cited 2020 Aug 07]. Available from: http://dspace.library.uu.nl:8080/handle/1874/267996.

Council of Science Editors:

Leijen S. Development of Combination Therapy with Anti-Cancer Drugs. [Doctoral Dissertation]. Universiteit Utrecht; 2013. Available from: http://dspace.library.uu.nl:8080/handle/1874/267996


Universiteit Utrecht

19. van Hasselt, J.G.C. Integrated quantitative pharmacology for treatment optimization in oncology.

Degree: 2014, Universiteit Utrecht

 This thesis describes the development and application of quantitative pharmacological models in oncology for treatment optimization and for the design and analysis of clinical trials… (more)

Subjects/Keywords: pharmacokinetics; pharmacodynamics; oncology; clinical pharmacology; modelling; pharmacometrics; special populations; drug development

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

van Hasselt, J. G. C. (2014). Integrated quantitative pharmacology for treatment optimization in oncology. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/309225

Chicago Manual of Style (16th Edition):

van Hasselt, J G C. “Integrated quantitative pharmacology for treatment optimization in oncology.” 2014. Doctoral Dissertation, Universiteit Utrecht. Accessed August 07, 2020. http://dspace.library.uu.nl:8080/handle/1874/309225.

MLA Handbook (7th Edition):

van Hasselt, J G C. “Integrated quantitative pharmacology for treatment optimization in oncology.” 2014. Web. 07 Aug 2020.

Vancouver:

van Hasselt JGC. Integrated quantitative pharmacology for treatment optimization in oncology. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2014. [cited 2020 Aug 07]. Available from: http://dspace.library.uu.nl:8080/handle/1874/309225.

Council of Science Editors:

van Hasselt JGC. Integrated quantitative pharmacology for treatment optimization in oncology. [Doctoral Dissertation]. Universiteit Utrecht; 2014. Available from: http://dspace.library.uu.nl:8080/handle/1874/309225


Washington State University

20. [No author]. Analytical Method Development, Pharmacokinetics, and Pharmacodynamics of Selected Polyphenols .

Degree: 2010, Washington State University

 Novel analytical methods were developed and validated according to the International Conference on Harmonization guidelines using high-performance liquid chromatography (HPLC) with ultraviolet (UV) and/or electrospray… (more)

Subjects/Keywords: analytical method; pharmacodynamics; pharmacokinetics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

author], [. (2010). Analytical Method Development, Pharmacokinetics, and Pharmacodynamics of Selected Polyphenols . (Thesis). Washington State University. Retrieved from http://hdl.handle.net/2376/2780

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

author], [No. “Analytical Method Development, Pharmacokinetics, and Pharmacodynamics of Selected Polyphenols .” 2010. Thesis, Washington State University. Accessed August 07, 2020. http://hdl.handle.net/2376/2780.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

author], [No. “Analytical Method Development, Pharmacokinetics, and Pharmacodynamics of Selected Polyphenols .” 2010. Web. 07 Aug 2020.

Vancouver:

author] [. Analytical Method Development, Pharmacokinetics, and Pharmacodynamics of Selected Polyphenols . [Internet] [Thesis]. Washington State University; 2010. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2376/2780.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

author] [. Analytical Method Development, Pharmacokinetics, and Pharmacodynamics of Selected Polyphenols . [Thesis]. Washington State University; 2010. Available from: http://hdl.handle.net/2376/2780

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

21. Chirehwa, Maxwell Tawanda. Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment.

Degree: Image, Division of Clinical Pharmacology, 2018, University of Cape Town

 The pharmacokinetics of rifampicin, isoniazid, pyrazinamide and ethambutol in TB/HIV coinfected patients recruited in two phase III clinical trials (61 patients in TB-HAART and 222… (more)

Subjects/Keywords: population; Nonlinear mixed-effects modelling; pharmacokinetics; tuberculos pharmacodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chirehwa, M. T. (2018). Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment. (Thesis). University of Cape Town. Retrieved from http://hdl.handle.net/11427/28429

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Chirehwa, Maxwell Tawanda. “Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment.” 2018. Thesis, University of Cape Town. Accessed August 07, 2020. http://hdl.handle.net/11427/28429.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Chirehwa, Maxwell Tawanda. “Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment.” 2018. Web. 07 Aug 2020.

Vancouver:

Chirehwa MT. Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment. [Internet] [Thesis]. University of Cape Town; 2018. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/11427/28429.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Chirehwa MT. Population/ Nonlinear mixed-effects modelling of pharmacokinetics and pharmacodynamics of tuberculosis treatment. [Thesis]. University of Cape Town; 2018. Available from: http://hdl.handle.net/11427/28429

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

22. Bourguignon, Laurent. Modélisation pharmacocinétique-pharmacodynamique et techniques de simulation appliquées à l’évaluation de stratégies thérapeutiques en infectiologie : Pharmacokinetic pharmacodynamic modeling and simulation methods applied to evaluation of therapeutic strategies.

Degree: Docteur es, Pharmacologie, 2009, Université Claude Bernard – Lyon I

La médecine actuelle, basée sur les preuves, et la recherche de standardisation qui l’accompagne, sont-elles compatibles avec la variabilité intra- et interindividuelle de la réponse… (more)

Subjects/Keywords: Modélisation; Pharmacocinétique; Pharmacodynamie; Evaluation; Simulation; Modeling; Pharmacokinetics; Pharmacodynamics; Evaluation; Simulation; 570.151

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bourguignon, L. (2009). Modélisation pharmacocinétique-pharmacodynamique et techniques de simulation appliquées à l’évaluation de stratégies thérapeutiques en infectiologie : Pharmacokinetic pharmacodynamic modeling and simulation methods applied to evaluation of therapeutic strategies. (Doctoral Dissertation). Université Claude Bernard – Lyon I. Retrieved from http://www.theses.fr/2009LYO10243

Chicago Manual of Style (16th Edition):

Bourguignon, Laurent. “Modélisation pharmacocinétique-pharmacodynamique et techniques de simulation appliquées à l’évaluation de stratégies thérapeutiques en infectiologie : Pharmacokinetic pharmacodynamic modeling and simulation methods applied to evaluation of therapeutic strategies.” 2009. Doctoral Dissertation, Université Claude Bernard – Lyon I. Accessed August 07, 2020. http://www.theses.fr/2009LYO10243.

MLA Handbook (7th Edition):

Bourguignon, Laurent. “Modélisation pharmacocinétique-pharmacodynamique et techniques de simulation appliquées à l’évaluation de stratégies thérapeutiques en infectiologie : Pharmacokinetic pharmacodynamic modeling and simulation methods applied to evaluation of therapeutic strategies.” 2009. Web. 07 Aug 2020.

Vancouver:

Bourguignon L. Modélisation pharmacocinétique-pharmacodynamique et techniques de simulation appliquées à l’évaluation de stratégies thérapeutiques en infectiologie : Pharmacokinetic pharmacodynamic modeling and simulation methods applied to evaluation of therapeutic strategies. [Internet] [Doctoral dissertation]. Université Claude Bernard – Lyon I; 2009. [cited 2020 Aug 07]. Available from: http://www.theses.fr/2009LYO10243.

Council of Science Editors:

Bourguignon L. Modélisation pharmacocinétique-pharmacodynamique et techniques de simulation appliquées à l’évaluation de stratégies thérapeutiques en infectiologie : Pharmacokinetic pharmacodynamic modeling and simulation methods applied to evaluation of therapeutic strategies. [Doctoral Dissertation]. Université Claude Bernard – Lyon I; 2009. Available from: http://www.theses.fr/2009LYO10243


North-West University

23. Viljoen, Michelle. Population pharmacokinetic and pharmacodynamic study of efavirenz in HIV–1–infected children treated with first line antiretroviral therapy in South Africa / Viljoen, M.

Degree: 2011, North-West University

 Highly active antiretroviral therapy (HAART) has improved the life expectancy of HIV–1–infected patients dramatically since it was launched in 1996, but there are still many… (more)

Subjects/Keywords: Efavirenz; Pharmacokinetics; Pharmacodynamics; Pharmacogenetics; Clearance; Efavirens; Farmakokinetika; Farmakodinamika; Farmakogenetika; Opruiming

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Viljoen, M. (2011). Population pharmacokinetic and pharmacodynamic study of efavirenz in HIV–1–infected children treated with first line antiretroviral therapy in South Africa / Viljoen, M. (Thesis). North-West University. Retrieved from http://hdl.handle.net/10394/6982

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Viljoen, Michelle. “Population pharmacokinetic and pharmacodynamic study of efavirenz in HIV–1–infected children treated with first line antiretroviral therapy in South Africa / Viljoen, M. ” 2011. Thesis, North-West University. Accessed August 07, 2020. http://hdl.handle.net/10394/6982.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Viljoen, Michelle. “Population pharmacokinetic and pharmacodynamic study of efavirenz in HIV–1–infected children treated with first line antiretroviral therapy in South Africa / Viljoen, M. ” 2011. Web. 07 Aug 2020.

Vancouver:

Viljoen M. Population pharmacokinetic and pharmacodynamic study of efavirenz in HIV–1–infected children treated with first line antiretroviral therapy in South Africa / Viljoen, M. [Internet] [Thesis]. North-West University; 2011. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10394/6982.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Viljoen M. Population pharmacokinetic and pharmacodynamic study of efavirenz in HIV–1–infected children treated with first line antiretroviral therapy in South Africa / Viljoen, M. [Thesis]. North-West University; 2011. Available from: http://hdl.handle.net/10394/6982

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Toronto

24. Rafat, Bijan. Abuse Liability of Controlled-release Oxycodone Formulations.

Degree: 2016, University of Toronto

Controlled-release opioid formulations may have differential abuse liability profiles related to rates of drug delivery. In this double-blind, placebo-controlled, randomized, crossover study, the abuse liability… (more)

Subjects/Keywords: Abuse Liability; Controlled-Release; Oxycodone; Pharmacodynamics; Pharmacokinetics; 0572

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rafat, B. (2016). Abuse Liability of Controlled-release Oxycodone Formulations. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/71688

Chicago Manual of Style (16th Edition):

Rafat, Bijan. “Abuse Liability of Controlled-release Oxycodone Formulations.” 2016. Masters Thesis, University of Toronto. Accessed August 07, 2020. http://hdl.handle.net/1807/71688.

MLA Handbook (7th Edition):

Rafat, Bijan. “Abuse Liability of Controlled-release Oxycodone Formulations.” 2016. Web. 07 Aug 2020.

Vancouver:

Rafat B. Abuse Liability of Controlled-release Oxycodone Formulations. [Internet] [Masters thesis]. University of Toronto; 2016. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/1807/71688.

Council of Science Editors:

Rafat B. Abuse Liability of Controlled-release Oxycodone Formulations. [Masters Thesis]. University of Toronto; 2016. Available from: http://hdl.handle.net/1807/71688


Kwame Nkrumah University of Science and Technology

25. Sarfo, Fred S.; Zhang, Yuan; Egan, Deirdre; Tetteh, Lambert A.; Phillips, Richard O. Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients.

Degree: 2013, Kwame Nkrumah University of Science and Technology

Objectives: Efavirenz is widely used in first-line antiretroviral therapy in sub-Saharan Africa. However, exposure to efavirenz shows marked interindividual variability that is genetically mediated with… (more)

Subjects/Keywords: non-nucleoside reverse transcriptase inhibitors; Africa; pharmacokinetics; pharmacodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sarfo, Fred S.; Zhang, Yuan; Egan, Deirdre; Tetteh, Lambert A.; Phillips, R. O. (2013). Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients. (Thesis). Kwame Nkrumah University of Science and Technology. Retrieved from http://dspace.knust.edu.gh:8080/jspui/handle/123456789/11869

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Sarfo, Fred S.; Zhang, Yuan; Egan, Deirdre; Tetteh, Lambert A.; Phillips, Richard O. “Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients.” 2013. Thesis, Kwame Nkrumah University of Science and Technology. Accessed August 07, 2020. http://dspace.knust.edu.gh:8080/jspui/handle/123456789/11869.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Sarfo, Fred S.; Zhang, Yuan; Egan, Deirdre; Tetteh, Lambert A.; Phillips, Richard O. “Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients.” 2013. Web. 07 Aug 2020.

Vancouver:

Sarfo, Fred S.; Zhang, Yuan; Egan, Deirdre; Tetteh, Lambert A.; Phillips RO. Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients. [Internet] [Thesis]. Kwame Nkrumah University of Science and Technology; 2013. [cited 2020 Aug 07]. Available from: http://dspace.knust.edu.gh:8080/jspui/handle/123456789/11869.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Sarfo, Fred S.; Zhang, Yuan; Egan, Deirdre; Tetteh, Lambert A.; Phillips RO. Pharmacogenetic associations with plasma efavirenz concentrations and clinical correlates in a retrospective cohort of Ghanaian HIV-infected patients. [Thesis]. Kwame Nkrumah University of Science and Technology; 2013. Available from: http://dspace.knust.edu.gh:8080/jspui/handle/123456789/11869

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of California – San Francisco

26. Goswami, Srijib. Novel Computational Methods to Discover Genes Linked to Drug Response.

Degree: Pharmaceutical Sciences and Pharmacogenomics, 2015, University of California – San Francisco

 Metformin is used first line for treatment of type 2 diabetes (T2D) and is one of the most frequently prescribed drugs worldwide. As the global… (more)

Subjects/Keywords: Pharmaceutical sciences; Genetics; pharmacodynamics; pharmacogenomics; pharmacokinetics; pharmacometrics; transporter

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Goswami, S. (2015). Novel Computational Methods to Discover Genes Linked to Drug Response. (Thesis). University of California – San Francisco. Retrieved from http://www.escholarship.org/uc/item/59g8108v

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Goswami, Srijib. “Novel Computational Methods to Discover Genes Linked to Drug Response.” 2015. Thesis, University of California – San Francisco. Accessed August 07, 2020. http://www.escholarship.org/uc/item/59g8108v.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Goswami, Srijib. “Novel Computational Methods to Discover Genes Linked to Drug Response.” 2015. Web. 07 Aug 2020.

Vancouver:

Goswami S. Novel Computational Methods to Discover Genes Linked to Drug Response. [Internet] [Thesis]. University of California – San Francisco; 2015. [cited 2020 Aug 07]. Available from: http://www.escholarship.org/uc/item/59g8108v.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Goswami S. Novel Computational Methods to Discover Genes Linked to Drug Response. [Thesis]. University of California – San Francisco; 2015. Available from: http://www.escholarship.org/uc/item/59g8108v

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of New South Wales

27. Kumar, Shaun. Exploring the value of population pharmacokinetic and pharmacodynamic modelling: in infectious disease, cancer and diabetes.

Degree: Medical Sciences, 2016, University of New South Wales

 Dose selection is a critical part of individualising pharmacotherapy in order to ensure optimal safety and effectiveness. Population pharmacokinetic and/or pharmacodynamic modelling paired with Bayesian… (more)

Subjects/Keywords: Population pharmacodynamics; Pharmacometrics; Population pharmacokinetics; Ribavirin; Imatinib; Metformin; Dose individualisation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kumar, S. (2016). Exploring the value of population pharmacokinetic and pharmacodynamic modelling: in infectious disease, cancer and diabetes. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/55575 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:38076/SOURCE02?view=true

Chicago Manual of Style (16th Edition):

Kumar, Shaun. “Exploring the value of population pharmacokinetic and pharmacodynamic modelling: in infectious disease, cancer and diabetes.” 2016. Doctoral Dissertation, University of New South Wales. Accessed August 07, 2020. http://handle.unsw.edu.au/1959.4/55575 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:38076/SOURCE02?view=true.

MLA Handbook (7th Edition):

Kumar, Shaun. “Exploring the value of population pharmacokinetic and pharmacodynamic modelling: in infectious disease, cancer and diabetes.” 2016. Web. 07 Aug 2020.

Vancouver:

Kumar S. Exploring the value of population pharmacokinetic and pharmacodynamic modelling: in infectious disease, cancer and diabetes. [Internet] [Doctoral dissertation]. University of New South Wales; 2016. [cited 2020 Aug 07]. Available from: http://handle.unsw.edu.au/1959.4/55575 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:38076/SOURCE02?view=true.

Council of Science Editors:

Kumar S. Exploring the value of population pharmacokinetic and pharmacodynamic modelling: in infectious disease, cancer and diabetes. [Doctoral Dissertation]. University of New South Wales; 2016. Available from: http://handle.unsw.edu.au/1959.4/55575 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:38076/SOURCE02?view=true


University of Sydney

28. Lin, Yu-Wei. ROLES OF AEROSOLISED POLYMYXINS FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS: A STEP TOWARDS DOSE OPTIMISATION .

Degree: 2017, University of Sydney

 Antibiotic resistance is a major global health challenge. Due to the dry antibiotic discovery pipeline, polymyxins are used as the last-line therapy against Gram- negative… (more)

Subjects/Keywords: Polymyrins; Multidrug Resistant; Lung Infections; Pharmacokinetics; Pharmacodynamics; Inhalation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lin, Y. (2017). ROLES OF AEROSOLISED POLYMYXINS FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS: A STEP TOWARDS DOSE OPTIMISATION . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/17820

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lin, Yu-Wei. “ROLES OF AEROSOLISED POLYMYXINS FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS: A STEP TOWARDS DOSE OPTIMISATION .” 2017. Thesis, University of Sydney. Accessed August 07, 2020. http://hdl.handle.net/2123/17820.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lin, Yu-Wei. “ROLES OF AEROSOLISED POLYMYXINS FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS: A STEP TOWARDS DOSE OPTIMISATION .” 2017. Web. 07 Aug 2020.

Vancouver:

Lin Y. ROLES OF AEROSOLISED POLYMYXINS FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS: A STEP TOWARDS DOSE OPTIMISATION . [Internet] [Thesis]. University of Sydney; 2017. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2123/17820.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lin Y. ROLES OF AEROSOLISED POLYMYXINS FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS: A STEP TOWARDS DOSE OPTIMISATION . [Thesis]. University of Sydney; 2017. Available from: http://hdl.handle.net/2123/17820

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Uppsala University

29. Strömberg, Eric. Faster Optimal Design Calculations for Practical Applications.

Degree: Pharmaceutical Biosciences, 2011, Uppsala University

  PopED is a software developed by the Pharmacometrics Research Group at the Department of Pharmaceutical Biosiences, Uppsala University written mainly in MATLAB. It uses… (more)

Subjects/Keywords: Optimal Design; PopED; pharmacometrics; pharmacokinetics; pharmacodynamics; Fisher Information Matrix; parallelization

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Strömberg, E. (2011). Faster Optimal Design Calculations for Practical Applications. (Thesis). Uppsala University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-150802

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Strömberg, Eric. “Faster Optimal Design Calculations for Practical Applications.” 2011. Thesis, Uppsala University. Accessed August 07, 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-150802.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Strömberg, Eric. “Faster Optimal Design Calculations for Practical Applications.” 2011. Web. 07 Aug 2020.

Vancouver:

Strömberg E. Faster Optimal Design Calculations for Practical Applications. [Internet] [Thesis]. Uppsala University; 2011. [cited 2020 Aug 07]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-150802.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Strömberg E. Faster Optimal Design Calculations for Practical Applications. [Thesis]. Uppsala University; 2011. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-150802

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Gothenburg / Göteborgs Universitet

30. Friberg Hietala, Sofia. Clinical pharmacokinetics and pharmacodynamics of antimalarial combination therapy.

Degree: 2009, University of Gothenburg / Göteborgs Universitet

 In the face of growing drug resistance, the World Health Organization (WHO) has issued recommendations strongly encouraging the use of combination therapies to combat uncomplicated… (more)

Subjects/Keywords: pharmacokinetics; pharmacodynamics; antimalarials; artemisinins

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Friberg Hietala, S. (2009). Clinical pharmacokinetics and pharmacodynamics of antimalarial combination therapy. (Thesis). University of Gothenburg / Göteborgs Universitet. Retrieved from http://hdl.handle.net/2077/19644

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Friberg Hietala, Sofia. “Clinical pharmacokinetics and pharmacodynamics of antimalarial combination therapy.” 2009. Thesis, University of Gothenburg / Göteborgs Universitet. Accessed August 07, 2020. http://hdl.handle.net/2077/19644.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Friberg Hietala, Sofia. “Clinical pharmacokinetics and pharmacodynamics of antimalarial combination therapy.” 2009. Web. 07 Aug 2020.

Vancouver:

Friberg Hietala S. Clinical pharmacokinetics and pharmacodynamics of antimalarial combination therapy. [Internet] [Thesis]. University of Gothenburg / Göteborgs Universitet; 2009. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2077/19644.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Friberg Hietala S. Clinical pharmacokinetics and pharmacodynamics of antimalarial combination therapy. [Thesis]. University of Gothenburg / Göteborgs Universitet; 2009. Available from: http://hdl.handle.net/2077/19644

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

[1] [2] [3] [4] [5] [6] [7]

.